DDO-2213 is a Potent and Orally Bioavailable Inhibitor of the WDR5−Mixed Lineage Leukemia 1 Protein−Protein Interaction for the Treatment of MLL Fusion Leukemia.
MedKoo Cat#: 464856
Name: DDO-2213
CAS#: unknown
Chemical Formula: C24H28ClFN8O
Exact Mass: 498.2059
Molecular Weight: 498.99
Elemental Analysis: C, 57.77; H, 5.66; Cl, 7.10; F, 3.81; N, 22.46; O, 3.21
The following data is based on the product molecular weight 498.99 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
